Herishanu, Y., Goldschmidt, N., Bairey, O., Ruchlemer, R., Fineman, R., Rahimi-Levene, N., Shvidel, L., Tadmor, T., Ariel, A., Braester, A., Shapiro, M., Joffe, E., Polliack, A. and on behalf of the Israeli CLL Study Group (2015) “Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience”, Haematologica. Pavia, Italy, 100(5), pp. 662-669. doi: 10.3324/haematol.2014.115808.